Pneumovesical ureteric reimplantation has gained increasing popularity for the treatment of vesicoureteric reflux and vesicoureteric junction obstruction in pediatric patients. In this study we reviewed our experience at an intermediate term basis.
Introduction
Disease process involving the vesicoureteric junction is a common problem in pediatric urology practice. Vesicoureteric reflux (VUR) and vesicoureteric junction obstruction (VUJO) comprise the majority of this condition. Ureteric reimplantation remains the definitive treatment for patients with VUJO. While there are different choices for the management of VUR, ureteric reimplantation serves as the ultimate option for patients who failed medical treatment or endoscopic therapy 1 Previously we have reported our early series with the first few cases of laparoscopic pneumovesical ureteric reimplantation in 2008 6 . Here we reviewed the results of our patients at an intermediate term basis after a decade of experience.
Materials and methods
This is a retrospective review of all pediatric patients with pneumovesical ureteric reimplantation performed in our centre between January 2005 and December 2015.
Medical and operative records were retrieved for study. Patients' demographics, preoperative diagnoses, operative measures and post-operative outcomes were extracted from the records.
All patients received either voiding cystourethrogram or MAG-3 scan before the operation to confirm their diagnosis. For VUR patients, operation was offered to those with high grade disease (grade IV to V) or to patients with low grade disease but presented with breakthrough urinary tract infection despite compliant to antibiotics.
Patients with residual high grade VUR or recurrent urinary tract infection following previous endoscopic injection therapy were also considered as indication for operation.
Similarly, all patients with significant VUJO on MAG-3 scan were offered operation.
The pneumovesical operative technique was similar to previously described 5, 6 , which involves bladder insufflation with carbon dioxide to create pneumovesicum. Following bladder anchoring and insertion of three 5mm
Step ports, the distal ureter was dissected out same as the open Cohen method. The freed distal ureter was then brought through a submucosal tunnel created over the bladder trigone, and subsequently anchored using monofilament nonabsorbable sutures. The operative technique was similar for both VUR and VUJO patients. Patients were discharged home once they became asymptomatic with all catheters removed. After the operations, voiding cystourethrogram or MAG-3 scan was performed at 3 months interval to assess any residual or recurrent disease.
Results
A total of 31 patients were identified during the study period. 9 males and 22 females.
The mean age at operation was 6. VUR was still the main indication for ureteric reimplantation 9, 10 . The best treatment approach for VUR is yet a highly debatable topic 11 . Despite the wider application of endoscopic injection therapy, some patients have residual reflux with repeated injections 1 .
The low residual or recurrence rate from our data means that pneumovesical approach is a safe alternative. 4 of our VUR procedures were found to have residual disease after operation, all of them being low grade and were managed successfully with conservative treatment. Interestingly in the 4 patients who required conversion to open approach, 3 of them had previous history of endoscopic injection therapy. We postulated that it was the dextranomer-hyaluronic acid compound injected around the ureteric orifice previously which resulted in severe adhesion and fibrosis, making distal ureter dissection difficult and required a conversion. Pneumovesical reimplantation may therefore be justified as the first line treatment in patients with high grade reflux owing to the increased operative difficulty and risks following previous endoscopic injection treatment.
The use of pneumovesical reimplantation has extended beyond its original application on VUR to include VUJO into the spectrum. There had been recent studies by Bi et al and Liu et al focusing mainly on primary obstructive megaureter 12, 13 . Conclusion from these studies all agreed that the pneumovesical approach is as effective as traditional open reimplantation. Bi et al employed the same cross-trigonal approach as we described and the result has been highly successful with only one residual obstruction out of the 61 procedures performed. Liu et al also reported improvement in over 90% of cases. Data from our series concurred with the above findings with no residual or recurrent obstruction seen in any of the VUJO patients after the operation.
In conclusion, pneumovesical ureteric reimplantation is safe and effective for pediatric patients. It can be applied to patients with VUR and VUJO. Intermediate term result confirmed its reliability and low recurrence rate. It has good potential to become the preferred approach of choice in the future.
